Literature DB >> 26997260

PELP1: Structure, biological function and clinical significance.

Gangadhara Reddy Sareddy1, Ratna K Vadlamudi2.   

Abstract

Proline-, glutamic acid-, and leucine-rich protein 1 (PELP1) is a scaffolding protein that functions as a coregulator of several transcription factors and nuclear receptors. Notably, the PELP1 protein has a histone-binding domain, recognizes histone modifications and interacts with several chromatin-modifying complexes. PELP1 serves as a substrate of multitude of kinases, and phosphorylation regulates its functions in various complexes. Further, PELP1 plays essential roles in several pathways including hormonal signaling, cell cycle progression, ribosomal biogenesis, and the DNA damage response. PELP1 expression is upregulated in several cancers, its deregulation contributes to therapy resistance, and it is a prognostic biomarker for breast cancer survival. Recent evidence suggests that PELP1 represents a novel therapeutic target for many hormonal cancers. In this review, we summarized the emerging biological properties and functions of PELP1.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Coregulator; Estrogen receptor; Hormonal action; Nuclear receptor; PELP1; Signal transduction; Transcriptional activation

Mesh:

Substances:

Year:  2016        PMID: 26997260      PMCID: PMC4838531          DOI: 10.1016/j.gene.2016.03.017

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  74 in total

1.  Prognostic value of novel biomarkers in astrocytic brain tumors: nuclear receptor co-regulators AIB1, TIF2, and PELP1 are associated with high tumor grade and worse patient prognosis.

Authors:  Zinovia Kefalopoulou; Vassiliki Tzelepi; Vassiliki Zolota; Petros D Grivas; Christos Christopoulos; Haralabos Kalofonos; Theodoros Maraziotis; Georgia Sotiropoulou-Bonikou
Journal:  J Neurooncol       Date:  2011-07-07       Impact factor: 4.130

2.  Cloning, distribution, and colocalization of MNAR/PELP1 with glucocorticoid receptors in primate and nonprimate brain.

Authors:  Mohammad M Khan; Martin Hadman; Liesl M De Sevilla; Virendra B Mahesh; Jerry Buccafusco; William D Hill; Darrell W Brann
Journal:  Neuroendocrinology       Date:  2006-12-01       Impact factor: 4.914

3.  Significance of PELP1 in ER-negative breast cancer metastasis.

Authors:  Sudipa Roy; Dimple Chakravarty; Valerie Cortez; Keya De Mukhopadhyay; Abhik Bandyopadhyay; Jung-Mo Ahn; Ganesh V Raj; Rajeshwar R Tekmal; LuZhe Sun; Ratna K Vadlamudi
Journal:  Mol Cancer Res       Date:  2011-11-15       Impact factor: 5.852

4.  PELP1 overexpression in the mouse mammary gland results in the development of hyperplasia and carcinoma.

Authors:  Valerie Cortez; Cathy Samayoa; Andrea Zamora; Lizatte Martinez; Rajeshwar R Tekmal; Ratna K Vadlamudi
Journal:  Cancer Res       Date:  2014-11-06       Impact factor: 12.701

5.  Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.

Authors:  Jesper V Olsen; Blagoy Blagoev; Florian Gnad; Boris Macek; Chanchal Kumar; Peter Mortensen; Matthias Mann
Journal:  Cell       Date:  2006-11-03       Impact factor: 41.582

6.  The cell fate determination factor DACH1 is expressed in estrogen receptor-alpha-positive breast cancer and represses estrogen receptor-alpha signaling.

Authors:  Vladimir M Popov; Jie Zhou; L Andrew Shirley; Judy Quong; Wen-Shuz Yeow; Jennifer A Wright; Kongming Wu; Hallgeir Rui; Ratna K Vadlamudi; Jie Jiang; Rakesh Kumar; Chenguang Wang; Richard G Pestell
Journal:  Cancer Res       Date:  2009-07-15       Impact factor: 12.701

7.  Identifying the estrogen receptor coactivator PELP1 in autophagosomes.

Authors:  Kazufumi Ohshiro; Suresh K Rayala; Seiji Kondo; Amitabh Gaur; Ratna K Vadlamudi; Adel K El-Naggar; Rakesh Kumar
Journal:  Cancer Res       Date:  2007-09-01       Impact factor: 12.701

8.  The prognostic significance of PELP1 expression in invasive breast cancer with emphasis on the ER-positive luminal-like subtype.

Authors:  Hany Onsy Habashy; Desmond G Powe; Emad A Rakha; Graham Ball; R Douglas Macmillan; Andrew R Green; Ian O Ellis
Journal:  Breast Cancer Res Treat       Date:  2009-06-03       Impact factor: 4.872

9.  Significance of PELP1/HDAC2/miR-200 regulatory network in EMT and metastasis of breast cancer.

Authors:  S S Roy; V K Gonugunta; A Bandyopadhyay; M K Rao; G J Goodall; L-Z Sun; R R Tekmal; R K Vadlamudi
Journal:  Oncogene       Date:  2013-08-26       Impact factor: 9.867

10.  Progesterone receptor-B enhances estrogen responsiveness of breast cancer cells via scaffolding PELP1- and estrogen receptor-containing transcription complexes.

Authors:  A R Daniel; A L Gaviglio; T P Knutson; J H Ostrander; A B D'Assoro; P Ravindranathan; Y Peng; G V Raj; D Yee; C A Lange
Journal:  Oncogene       Date:  2014-01-27       Impact factor: 9.867

View more
  14 in total

1.  PELP1 signaling contributes to medulloblastoma progression by regulating the NF-κB pathway.

Authors:  Yiliao Luo; Mengxing Li; Uday P Pratap; Suryavathi Viswanadhapalli; Junhao Liu; Prabhakar P Venkata; Kristin A Altwegg; Bridgitte E Palacios; Xiaonan Li; Yihong Chen; Manjeet K Rao; Andrew J Brenner; Gangadhara R Sareddy; Ratna K Vadlamudi
Journal:  Mol Carcinog       Date:  2019-12-24       Impact factor: 4.784

Review 2.  PELP1: a key mediator of oestrogen signalling and actions in the brain.

Authors:  R Thakkar; G R Sareddy; Q Zhang; R Wang; R K Vadlamudi; D Brann
Journal:  J Neuroendocrinol       Date:  2018-02       Impact factor: 3.627

3.  Clinical Evaluation of Proline, Glutamic acid, and Leucine-Rich Protein 1 Expression in Astrocytomas and Correlations with the Proliferation Marker Ki-67.

Authors:  Karthika P Padmavathy; Veena Kumari Vuttaradhi; Akkanapally Venu; Lawrence D'Cruze; Roshni Saravanan; Ravishankar Pitani; Krishnamurthy Ganesh; Himavani Pacharla; Suresh Kumar Rayala; D Prathiba; Ganesh Venkatraman
Journal:  J Mol Neurosci       Date:  2020-09-22       Impact factor: 3.444

4.  Cancer Stem Cell Phenotypes in ER+ Breast Cancer Models Are Promoted by PELP1/AIB1 Complexes.

Authors:  Thu H Truong; Hsiangyu Hu; Nuri A Temiz; Kyla M Hagen; Brian J Girard; Nicholas J Brady; Kathryn L Schwertfeger; Carol A Lange; Julie H Ostrander
Journal:  Mol Cancer Res       Date:  2018-01-18       Impact factor: 5.852

5.  NLRP3 Inflammasome Activation in the Brain after Global Cerebral Ischemia and Regulation by 17β-Estradiol.

Authors:  Roshni Thakkar; Ruimin Wang; Gangadhara Sareddy; Jing Wang; Dharma Thiruvaiyaru; Ratna Vadlamudi; Quanguang Zhang; Darrell Brann
Journal:  Oxid Med Cell Longev       Date:  2016-10-23       Impact factor: 6.543

6.  The Clinical Value of PELP1 for Breast Cancer: A Comparison with Multiple Cancers and Analysis in Breast Cancer Subtypes.

Authors:  Xingen Wang; Julia Y S Tsang; Michelle A Lee; Yun-Bi Ni; Joanna H Tong; Siu-Ki Chan; Sai-Yin Cheung; Ka Fai To; Gary M Tse
Journal:  Cancer Res Treat       Date:  2018-08-23       Impact factor: 4.679

7.  A conserved RNA degradation complex required for spreading and epigenetic inheritance of heterochromatin.

Authors:  Gergana Shipkovenska; Alexander Durango; Marian Kalocsay; Steven P Gygi; Danesh Moazed
Journal:  Elife       Date:  2020-06-03       Impact factor: 8.140

8.  PELP1 promotes glioblastoma progression by enhancing Wnt/β-catenin signaling.

Authors:  Gangadhara R Sareddy; Uday P Pratap; Suryavathi Viswanadhapalli; Prabhakar Pitta Venkata; Binoj C Nair; Samaya Rajeshwari Krishnan; Siyuan Zheng; Andrea R Gilbert; Andrew J Brenner; Darrell W Brann; Ratna K Vadlamudi
Journal:  Neurooncol Adv       Date:  2019-11-05

9.  Interaction of transcription factor AP-2 gamma with proto-oncogene PELP1 promotes tumorigenesis by enhancing RET signaling.

Authors:  Junhao Liu; Zexuan Liu; Mengxing Li; Weiwei Tang; Uday P Pratap; Yiliao Luo; Kristin A Altwegg; Xiaonan Li; Yi Zou; Hong Zhu; Gangadhara R Sareddy; Suryavathi Viswanadhapalli; Ratna K Vadlamudi
Journal:  Mol Oncol       Date:  2021-02-09       Impact factor: 6.603

10.  Overexpression of PELP1 in Lung Adenocarcinoma Promoted E2 Induced Proliferation, Migration and Invasion of the Tumor Cells and Predicted a Worse Outcome of the Patients.

Authors:  Dongmei Zhang; Jiali Dai; Yu Pan; Xiuli Wang; Juanjuan Qiao; Hironobu Sasano; Baoshan Zhao; Keely M McNamara; Xue Guan; Lili Liu; Yanzhi Zhang; Monica S M Chan; Shuwen Cao; Ming Liu; Sihang Song; Lin Wang
Journal:  Pathol Oncol Res       Date:  2021-04-02       Impact factor: 3.201

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.